Japer Therapeutics Warrants
JSPRW
14 hedge funds and large institutions have $135K invested in Japer Therapeutics Warrants in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 0 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
3.91% more ownership
Funds ownership: 0% → 3.91% (+3.9%)
0% more funds holding
Funds holding: 14 → 14 (0)
25% less capital invested
Capital invested by funds: $179K → $135K (-$44K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Ionic Capital Management
New York
|
+$8.18K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.38K |
| 3 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$202 |
| 4 |
PFM
Privium Fund Management
Amsterdam,
Netherlands
|
+$8 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$5.84K |
| 2 |
HF
HRT Financial
New York
|
-$424 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HCM
1
Highbridge Capital Management
New York
| $36K | – | – | – |
|
|
ICM
2
Ionic Capital Management
New York
| $36K | +$8.18K | +93,746 | +26% |
|
|
OCAM
3
Owl Creek Asset Management
New York
| $22K | – | – | – |
|
|
TCM
4
Tenor Capital Management
New York
| $15K | – | – | – |
|
|
PFM
5
Privium Fund Management
Amsterdam,
Netherlands
| $6K | +$8 | +91 | +0.1% |
|
|
ZA
6
Zazove Associates
Incline Village,
Nevada
| $5K | – | – | – |
|
|
SCM
7
Shaolin Capital Management
Miami,
Florida
| $4K | -$5.84K | -66,930 | -52% |
|
|
EPM
8
Equitec Proprietary Markets
Chicago,
Illinois
| $3K | – | – | – |
|
|
HF
9
HRT Financial
New York
| $2K | -$424 | -4,852 | -14% |
|
|
CAC
10
Cowen and Company
New York
| $2K | – | – | – |
|
11
Walleye Capital
New York
| $2K | – | – | – |
|
12
Walleye Trading
New York
| $1K | – | – | – |
|
|
13
UBS Group
Zurich,
Switzerland
| $1K | +$1.38K | +15,834 | +457% |
|
|
WAM
14
Wolverine Asset Management
Chicago,
Illinois
| – | +$202 | +2,317 | +28% |
|
JSPRW Hedge Fund Activity: Q3 2022 in Review
14 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Japer Therapeutics Warrants (JSPRW) for Q3 2022, worth a combined $135K — down 25% from $179K a quarter earlier.
Fund positioning in JSPRW was balanced in Q3 2022: 0 funds opened new positions, 0 closed out, 4 added to existing stakes and 2 trimmed.
The largest buyer was Ionic Capital Management, adding an estimated $8.18K. The largest seller was Shaolin Capital Management, cutting an estimated $5.84K.
- 14 institutional investors held Japer Therapeutics Warrants (JSPRW) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $135K of Japer Therapeutics Warrants stock for Q3 2022, down 25% quarter-over-quarter.
- 0 funds opened new Japer Therapeutics Warrants positions in Q3 2022 and 0 closed out.
- The largest Japer Therapeutics Warrants buyer in Q3 2022 was Ionic Capital Management, an estimated $8.18K added.
- The largest Japer Therapeutics Warrants seller in Q3 2022 was Shaolin Capital Management, an estimated $5.84K sold.
Based on aggregated 13F filings for Q3 2022.